secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2025-07-01T23:59:59+00:00
Accession:  0000950170-25-092318
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo regains Nasdaq compliance with $15.9M equity raise
---------------------------------------------------------

- Received Nasdaq notice confirming compliance with minimum $2.5M stockholders' equity rule.
- Raised ~$15.9M gross proceeds from equity capital in quarter ended June 30, 2025.
- Company previously disclosed non-compliance for quarter ended March 31, 2025.
- Believes stockholders' equity now exceeds $2.5M threshold.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025092318/0000950170-25-092318-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017025092318/apvo-20250701.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-092318

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer